Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$3.30 USD
+1.37 (70.98%)
Updated May 2, 2024 04:00 PM ET
After-Market: $3.30 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For EBS
-
Emergent Biosolutions: Q1 Earnings Snapshot
-
Emergent BioSolutions Reports First Quarter 2024 Financial Results
-
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
-
Emergent Biosolutions: Q4 Earnings Snapshot
-
Emergent Biosolutions: Q4 Earnings Snapshot
-
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates
-
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
-
Emergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimates
-
Emergent Biosolutions: Q3 Earnings Snapshot
-
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
-
Why Is Emergent Biosolutions (EBS) Down 22.6% Since Last Earnings Report?
-
Emergent (EBS) Q2 Earnings Miss Estimates, Revenues Beat
-
Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates
-
Emergent Biosolutions: Q2 Earnings Snapshot
-
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
-
Why Is Emergent Biosolutions (EBS) Down 21.4% Since Last Earnings Report?
-
Emergent (EBS) Q1 Earnings Miss Estimates, Revenues Beat
-
Emergent Biosolutions (EBS) Reports Q1 Loss, Tops Revenue Estimates
-
Emergent Biosolutions: Q1 Earnings Snapshot
-
Emergent BioSolutions Reports Financial Results For First Quarter 2023
-
Emergent Biosolutions (EBS) Expected to Beat Earnings Estimates: Should You Buy?
-
Emergent Biosolutions (EBS) Down 28.1% Since Last Earnings Report: Can It Rebound?
-
Emergent's (EBS) Q4 Earnings Miss, Sales Beat Estimates
-
Emergent Biosolutions: Q4 Earnings Snapshot
-
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates